Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Posts Basic Consolidated EPS Of $-0.4219

0

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)managed to report annual basic consolidated EPS of $-0.4219, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-0.4219 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.1111.

EPS contribution from parent

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) received of $-0.4219 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) contributed EPS of $-0.4219 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-0.4219.

What About Basic net EPS

The basic net EPS that Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) reported for the year ended 2015-12-31 stood at $-0.42. For the quarter ended 2015-12-31, the company posted basic net EPS of $-0.42.

What About Consolidated Diluted EPS?

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-0.4219. For the quarter ended 2015-12-31 the metric was$-0.4219.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-0.4219 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-0.4219.

Net diluted EPS

Net diluted EPS posted by Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) for the year ended 2015-12-31 was $-0.42. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-0.42.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) said that it parent company boosted its diluted EPS by$-0.4219 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-0.4219.

The company reported net basic EPS of $-0.42 for the year ended 2015-12-31 and net basic EPS of $-0.42 for the quarter ended 2015-12-31.

The number of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 115.092. That compares with 115.092 basic shares outstanding for the quarter ended 2015-12-31.

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) had 115.092 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 115.092.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 24 times, 1 visits today)